{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:14:39Z","timestamp":1791137679725,"version":"4.1.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2011,11,3]],"date-time":"2011-11-03T00:00:00Z","timestamp":1320278400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1002350","type":"journal-article","created":{"date-parts":[[2011,11,3]],"date-time":"2011-11-03T21:02:45Z","timestamp":1320354165000},"page":"e1002350","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":76,"title":["Fatal Prion Disease in a Mouse Model of Genetic E200K Creutzfeldt-Jakob Disease"],"prefix":"10.1371","volume":"7","author":[{"given":"Yael","family":"Friedman-Levi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeev","family":"Meiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Canello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati","family":"Frid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor G.","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Budka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Avrahami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Gabizon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,11,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","article-title":"Genetic prion disease: the EUROCJD experience.","volume":"118","author":"GG Kovacs","year":"2005","journal-title":"Hum Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1212\/WNL.40.12.1820","article-title":"Inherited human prion diseases.","volume":"40","author":"K Hsiao","year":"1990","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM199104183241604","article-title":"Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease.","volume":"324","author":"K Hsiao","year":"1991","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1749-6632.1991.tb00211.x","article-title":"A mutation in the prion protein gene in Creutzfeldt-Jakob disease in Jewish patients of Libyan, Greek, and Tunisian origin.","volume":"640","author":"AD Korczyn","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1086\/302340","article-title":"Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease.","volume":"64","author":"HS Lee","year":"1999","journal-title":"Am J Hum Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1212\/01.wnl.0000308955.25760.c2","article-title":"Systematic review of therapeutic interventions in human prion disease.","volume":"70","author":"LA Stewart","year":"2008","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1474-4422(09)70050-X","article-title":"Clinical trials for prion disease: difficult challenges, but hope for the future.","volume":"8","author":"MD Geschwind","year":"2009","journal-title":"Lancet Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/01.WNL.0000113764.35026.EF","article-title":"Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study.","volume":"62","author":"M Otto","year":"2004","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ana.410350504","article-title":"Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease.","volume":"35","author":"P Brown","year":"1994","journal-title":"Ann Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1750-3639.1995.tb00577.x","article-title":"Inherited prion diseases and transmission to rodents.","volume":"5","author":"J Tateishi","year":"1995","journal-title":"Brain Pathol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1051\/vetres:2008008","article-title":"Rodent models for prion diseases.","volume":"39","author":"MH Groschup","year":"2008","journal-title":"Vet Res"},{"key":"ref12","first-page":"51","article-title":"Prion neurotoxicity: insights from prion protein mutants.","volume":"12","author":"IH Solomon","year":"2010","journal-title":"Curr Issues Mol Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1126\/science.1980379","article-title":"Spontaneous neurodegeneration in transgenic mice with mutant prion protein.","volume":"250","author":"KK Hsiao","year":"1990","journal-title":"Science"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"9126","DOI":"10.1073\/pnas.91.19.9126","article-title":"Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein.","volume":"91","author":"KK Hsiao","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"9936","DOI":"10.1073\/pnas.91.21.9936","article-title":"Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein.","volume":"91","author":"GC Telling","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0896-6273(00)80653-4","article-title":"Neurological illness in transgenic mice expressing a prion protein with an insertional mutation.","volume":"21","author":"R Chiesa","year":"1998","journal-title":"Neuron"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"10072","DOI":"10.1523\/JNEUROSCI.2542-09.2009","article-title":"A New Transgenic Mouse Model of Gerstmann-Straussler-Scheinker Syndrome Caused by the A117V Mutation of PRNP.","volume":"29","author":"W Yang","year":"2009","journal-title":"J Neurosci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.neuron.2008.09.008","article-title":"Mutant prion protein expression causes motor and memory deficits and abnormal sleep patterns in a transgenic mouse model.","volume":"60","author":"S Dossena","year":"2008","journal-title":"Neuron"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.neuron.2009.07.026","article-title":"Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice.","volume":"63","author":"WS Jackson","year":"2009","journal-title":"Neuron"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1099\/vir.0.007930-0","article-title":"Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.","volume":"90","author":"EA Asante","year":"2009","journal-title":"J Gen Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1101\/gad.10.14.1736","article-title":"Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice.","volume":"10","author":"GC Telling","year":"1996","journal-title":"Genes Dev"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/pro.5560010804","article-title":"Chimeric prion protein expression in cultured cells and transgenic mice.","volume":"1","author":"MR Scott","year":"1992","journal-title":"Protein Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3390\/ijms10030976","article-title":"Molecular pathology of human prion diseases.","volume":"10","author":"GG Kovacs","year":"2009","journal-title":"Int J Mol Sci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00401-010-0713-y","article-title":"Genetic Creutzfeldt-Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy.","volume":"121","author":"GG Kovacs","year":"2010","journal-title":"Acta Neuropathol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ana.410040303","article-title":"Experimental scrapie in mice: ultrastructural observations.","volume":"4","author":"JR Baringer","year":"1978","journal-title":"Ann Neurol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e1000977","DOI":"10.1371\/journal.ppat.1000977","article-title":"Oxidation of Helix-3 methionines precedes the formation of PK resistant PrP.","volume":"6","author":"T Canello","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/pro.5560011014","article-title":"Purification and properties of the cellular prion protein from Syrian hamster brain.","volume":"1","author":"KM Pan","year":"1992","journal-title":"Protein Sci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0092-8674(95)90236-8","article-title":"Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein.","volume":"83","author":"GC Telling","year":"1995","journal-title":"Cell"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0092-8674(00)81572-X","article-title":"Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions.","volume":"93","author":"D Shmerling","year":"1998","journal-title":"Cell"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1126\/science.275.5298.402","article-title":"Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein.","volume":"275","author":"CI Lasmezas","year":"1997","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1073\/pnas.0409079102","article-title":"Strain-specified characteristics of mouse synthetic prions.","volume":"102","author":"G Legname","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00702-010-0476-6","article-title":"Transgenic animal models of neurodegeneration based on human genetic studies.","volume":"118","author":"BK Harvey","year":"2010","journal-title":"J Neural Transm"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2010.04.031","article-title":"Probing the biology of Alzheimer&apos;s disease in mice.","volume":"66","author":"KH Ashe","year":"2010","journal-title":"Neuron"},{"key":"ref34","first-page":"103","article-title":"A transgenic model of a familial prion disease.","author":"DA Harris","year":"2000","journal-title":"Arch Virol Suppl"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"38936","DOI":"10.1074\/jbc.M405468200","article-title":"Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes.","volume":"279","author":"G Zanusso","year":"2004","journal-title":"J Biol Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0002-9440(10)64572-5","article-title":"Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain.","volume":"157","author":"S Capellari","year":"2000","journal-title":"Am J Pathol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/1531-8249(200002)47:2<257::AID-ANA20>3.0.CO;2-U","article-title":"Creutzfeldt-Jakob disease profile in patients homozygous for the PRNP E200K mutation.","volume":"47","author":"ES Simon","year":"2000","journal-title":"Ann Neurol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1871526510909010023","article-title":"Tetracyclines and prion infectivity.","volume":"9","author":"G Forloni","year":"2009","journal-title":"Infect Disord Drug Targets"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/archneur.65.6.762","article-title":"Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.","volume":"65","author":"Y Haviv","year":"2008","journal-title":"Arch Neurol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/01.LAB.0000074919.08232.A2","article-title":"Differential inhibition of prion propagation by enantiomers of quinacrine.","volume":"83","author":"C Ryou","year":"2003","journal-title":"Lab Invest"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35089090","article-title":"Antibodies inhibit prion propagation and clear cell cultures of prion infectivity.","volume":"412","author":"D Peretz","year":"2001","journal-title":"Nature"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2174\/187152709789541934","article-title":"RNAi for the treatment of prion disease: a window for intervention in neurodegeneration?","volume":"8","author":"MD White","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/356577a0","article-title":"Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.","volume":"356","author":"H Bueler","year":"1992","journal-title":"Nature"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0092-8674(93)90275-U","article-title":"Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes.","volume":"73","author":"M Scott","year":"1993","journal-title":"Cell"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00004647-200002000-00019","article-title":"Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines.","volume":"20","author":"PF Stahel","year":"2000","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1128\/JVI.02502-08","article-title":"Prion protein glycosylation is not required for strain-specific neurotropism.","volume":"83","author":"JR Piro","year":"2009","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"12868","DOI":"10.1021\/bi025958g","article-title":"Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes.","volume":"41","author":"S Tzaban","year":"2002","journal-title":"Biochemistry"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1006294","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T00:00:00Z","timestamp":1493769600000}},{"DOI":"10.1371\/journal.ppat.1012774","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000}},{"DOI":"10.1371\/journal.ppat.1006294","type":"correction","label":"Correction","source":"retraction-watch","updated":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T00:00:00Z","timestamp":1493769600000},"record-id":"69784"},{"DOI":"10.1371\/journal.ppat.1012774","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"record-id":"69785"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1002350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T07:57:07Z","timestamp":1540367827000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1002350"}},"subtitle":[],"editor":[{"given":"David","family":"Westaway","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,11,3]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2011,11,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1002350","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.ppat.1006294","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,3]]}}}